(Q50970308)

26 March 2018

title

Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers. (English)

1 reference

26 March 2018

1 reference

1 reference

R Wootton

1

1 reference

26 March 2018

J Soul-Lawton

2

1 reference

26 March 2018

P E Rolan

3

1 reference

26 March 2018

C T Sheung

4

1 reference

26 March 2018

J D Cooper

5

1 reference

26 March 2018

J Posner

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

26 March 2018

British Journal of Clinical Pharmacology

published in

1 reference

26 March 2018

volume

43

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

23-27

1 reference

26 March 2018

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

Inhibition of phenobarbitone N-glucosidation by valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1997.TB00028.X

10.1111/J.1365-2125.1997.TB00028.X

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018